Federal award (DEFINITIVE CONTRACT, fiscal year 2023)
Recipient: REGENERON PHARMACEUTICALS INC
Awarding agency: Department of Health and Human Services / Office of Assistant Secretary for Preparedness and Response
Funding agency: Department of Health and Human Services / Office of Assistant Secretary for Preparedness and Response
Period of performance: 2017-09-30 to 2027-09-29
Current total value of award: $693056926.67
Description: NO COST MOD TO REVISE THE CONTRACT SECTIONS: ARTICLE B.2.2., B.4.Q., ARTICLE C.1., ARTICLE F.4, AND THE STATEMENT OF WORK. ADD ARTICLE B.4.R., ARTICLE H.31., AND FAR CLAUSE 52.204-27.